SK Biopharmaceuticals swings to profits in Q4

SK Biopharmaceuticals-Q4 earnings

SK Biopharmaceuticals swings to profits in Q4

SEOUL, Feb. 8 (Yonhap) -- SK Biopharmaceuticals Co. on Tuesday reported its fourth-quarter net income of 65.7 billion won (US$54.9 million), swinging from a loss of 58.1 billion won a year earlier.

Operating profit for the October-December period was 134.4 billion, compared with a loss of 53.5 billion won a year ago, the company said in a regulatory filing. Sales rose 1334.7 percent to 230.7 billion won.

(END)

(C) Yonhap News Agency. All Rights Reserved